Evidence map›Paper›PMID 33332210›Full record

ArticlePharmaceutical biology2020

Comprehensive study of dexamethasone on albumin biogenesis during normal and pathological renal conditions.

Qin Gong, Jilei Yin, Mulan Wang, Luling He, Fan Lei, Yingying Luo, Shilin Yang, Yulin Feng, Jun Li, Lijun Du

Open access · goldAbstract read
In one paragraph

Article in Pharmaceutical biology, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 8 papers.

0numbers the graph read from it
0cells of the map it votes in
8citing papers in PubMed
0.8field-weighted citation impact, top 26% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

8 citing papers in PubMed, 11 citations in OpenAlex.

  1. Review
  2. ORNIPURALFrontiers in veterinary science · 2025
    Article
  3. Role of TGF-β1/SMADs signalling pathway in resveratrol-induced reduction of extracellular matrix deposition by dexamethasone-treated human trabecular meshwork cells.The Korean journal of physiology & pharmacology : official journal of the Korean Physiological Society and the Korean Society of Pharmacology · 2024
    Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors at 3 institutions in 1 country.

Qin GongSchool of Pharmacy, Jiangxi University of Traditional Chinese Medicine, Nanchang, China.
Jilei YinDepartment of Traditional Chinese Medicine, Jiangsu Union Technical Institute Lianyungang Branch Institute of Traditional Chinese Medicine, Lianyungang, China.
Mulan WangPharmacology Laboratory, State Key Laboratory of Innovative Drugs and Efficient Energy-Saving Pharmaceutical Equipment, Nanchang, China.
Luling HeSchool of Pharmacy, Jiangxi University of Traditional Chinese Medicine, Nanchang, China.
Fan LeiSchool of Life Sciences, Tsinghua University, Beijing, China.
Yingying LuoSchool of Pharmacy, Jiangxi University of Traditional Chinese Medicine, Nanchang, China.
Shilin YangSchool of Pharmacy, Jiangxi University of Traditional Chinese Medicine, Nanchang, China.
Yulin FengSchool of Pharmacy, Jiangxi University of Traditional Chinese Medicine, Nanchang, China.
Jun LiSchool of Pharmacy, Jiangxi University of Traditional Chinese Medicine, Nanchang, China.
Lijun DuSchool of Pharmacy, Jiangxi University of Traditional Chinese Medicine, Nanchang, China.
State Key Laboratory of Food Science and Technology · CNJiangxi University of Traditional Chinese Medicine · CNTsinghua University · CN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

contextDexamethasone (DXM) has an anti-immunoinflammatory effect, and is often used in acute kidney injury (AKI). However, the effects of DXM on albumin (ALB) have not been fully studied.

objectiveTo investigate the effects of DXM on ALB production and renal function. MATERIALS AND

methodsMale Wistar rats were divided into normal and DXM groups (0.25, 0.5, 1 mg/kg for 5 days) (

resultsIn normal, serum ALB (sALB) and serum total protein (sTP) increased in DXM group with sALB increased 19.8-32.2% (from small to large dosages); and 30.2-32.5.6% (from 3 to 7 days of DXM); sTP 15.7-22.6% and 14.2-24.3%; urine ALB (uALB) 31.5-392.3%, and 1047.2-1390.8%; urine TP (uTP) 0.68-173.1% and 98.0-504.9%, compared with normal groups. DXM increased the mRNA expression of

conclusionsDXM acts on

Indexed as

Acute Kidney InjuryAnimalsBlood ProteinsCisplatinDexamethasoneDose-Response Relationship, DrugEnhancer Elements, GeneticKidneyMaleRatsRats, WistarSerum AlbuminBlood ProteinsCisplatinDexamethasoneSerum Albuminacute kidney injuryCisplatingene transcription start siteproteinuria

Identifiers

PMID33332210
PMCPMC7751422
OpenAlexW3110979931

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.